Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Relation Tx, a TechBio company, completed a $60M Seed funding round with investors including DCVC, Deerfield, NVIDIA, and Magnetic Ventures. DCVC led the funding alongside NVIDIA's NVentures. Venture Leader AlitheaGenomics secured CHF 2.8 million to expand to the US. Tubulis raised €128 in a Series B2 funding round with support from Seventure's funds.
Relation Therapeutics (@RelationRx) is a leading exemplar of a new wave of TechBio companies combining the power of ML with rapid, iterative lab experiments to generate massive proprietary data sets that enable real progress against complex human diseases. @dcvc is delighted…
🚀 Exciting News! We’re delighted to be part of @Tubulis_GmbH €128 Million Series B2 Funding Round which Seventure’s funds are supporting since 2020 🚀 https://t.co/U2GuAC26jI @IdeCremoux https://t.co/2jYSe0F9r3
Tubulis just raised €128 in a series B2 $ZYME $MRSN $ADCT https://t.co/wuYpmZEYO9
